Jon Hickman
Stock Analyst at Ladenburg Thalmann & Co.
(4.18)
# 1,461
Out of 4,382 analysts
133
Total ratings
43.8%
Success rate
12.4%
Average return
Main Sectors:
Stocks Rated by Jon Hickman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| USIO Usio, Inc. | Maintained: Buy | $5.5 → $6.25 | $1.51 | +313.91% | 9 | May 15, 2026 | |
| NOTE FiscalNote Holdings, Inc. | Maintained: Buy | $11 → $9.75 | $0.1702 | +5,628.55% | 2 | May 12, 2026 | |
| SRTA Strata Critical Medical | Reiterated: Buy | $11 → $12 | $5.79 | +98.62% | 7 | May 7, 2026 | |
| CORZ Core Scientific | Maintained: Buy | $15 → $24 | $25.85 | -8.12% | 3 | Mar 3, 2026 | |
| AMZE Amaze Holdings | Initiated Coverage: Buy | $3 | $0.1375 | +2,081.82% | 1 | Jan 21, 2026 | |
| INUV Inuvo | Reiterated: Buy | $1 → $12 | $1.41 | +715.60% | 3 | Nov 10, 2025 | |
| CLSK CleanSpark | Initiated Coverage: Buy | $20 | $15.59 | +29.89% | 1 | Jul 28, 2025 | |
| PAYS Paysign | Maintained: Buy | $7.25 → $8.25 | $6.79 | n/a | 9 | May 9, 2025 | |
| CREX Creative Realities | Initiated Coverage: Buy | $6 | $3.99 | n/a | 1 | Dec 16, 2024 | |
| BYRN Byrna Technologies | Maintained: Buy | $16 → $22 | $5.92 | n/a | 6 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.75 | $0.9961 | n/a | 1 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 | $25.49 | n/a | 11 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $8.5 | $6.02 | n/a | 8 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 1 | Dec 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $10 | $0.0111 | n/a | 3 | Feb 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.25 → $4.5 | $0.000001 | n/a | 12 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.25 → $2.1 | $1.29 | n/a | 9 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.15 → $80 | $3.11 | n/a | 2 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $13.74 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.15 → $4.5 | $3.71 | n/a | 10 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 | $9.01 | n/a | 11 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.4 | $1.11 | n/a | 3 | Nov 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $1.29 | n/a | 1 | Dec 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 → $10 | $0.0002 | n/a | 2 | Dec 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $12 | $0.133 | n/a | 3 | Jun 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 | $7.20 | n/a | 7 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $0.0012 | n/a | 3 | Nov 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $2.10 | n/a | 1 | May 9, 2013 |
Usio, Inc.
May 15, 2026
Maintained: Buy
Price Target: $5.5 → $6.25
Current: $1.51
Upside: +313.91%
FiscalNote Holdings, Inc.
May 12, 2026
Maintained: Buy
Price Target: $11 → $9.75
Current: $0.1702
Upside: +5,628.55%
Strata Critical Medical
May 7, 2026
Reiterated: Buy
Price Target: $11 → $12
Current: $5.79
Upside: +98.62%
Core Scientific
Mar 3, 2026
Maintained: Buy
Price Target: $15 → $24
Current: $25.85
Upside: -8.12%
Amaze Holdings
Jan 21, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.1375
Upside: +2,081.82%
Inuvo
Nov 10, 2025
Reiterated: Buy
Price Target: $1 → $12
Current: $1.41
Upside: +715.60%
CleanSpark
Jul 28, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $15.59
Upside: +29.89%
Paysign
May 9, 2025
Maintained: Buy
Price Target: $7.25 → $8.25
Current: $6.79
Upside: n/a
Creative Realities
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $3.99
Upside: n/a
Byrna Technologies
Oct 10, 2024
Maintained: Buy
Price Target: $16 → $22
Current: $5.92
Upside: n/a
Jun 12, 2024
Initiated Coverage: Buy
Price Target: $3.75
Current: $0.9961
Upside: n/a
May 16, 2024
Upgraded: Buy
Price Target: $2
Current: $25.49
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $8 → $8.5
Current: $6.02
Upside: n/a
Dec 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Feb 2, 2023
Maintained: Buy
Price Target: $14 → $10
Current: $0.0111
Upside: n/a
Aug 16, 2022
Maintained: Buy
Price Target: $6.25 → $4.5
Current: $0.000001
Upside: n/a
Aug 12, 2022
Downgraded: Hold
Price Target: $4.25 → $2.1
Current: $1.29
Upside: n/a
May 20, 2022
Maintained: Buy
Price Target: $3.15 → $80
Current: $3.11
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $12 → $14
Current: $13.74
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $4.15 → $4.5
Current: $3.71
Upside: n/a
Oct 30, 2020
Downgraded: Hold
Price Target: $32
Current: $9.01
Upside: n/a
Nov 18, 2019
Reiterated: Buy
Price Target: $2.4
Current: $1.11
Upside: n/a
Dec 20, 2017
Initiated Coverage: Buy
Price Target: $34
Current: $1.29
Upside: n/a
Dec 14, 2017
Upgraded: Buy
Price Target: $9 → $10
Current: $0.0002
Upside: n/a
Jun 13, 2017
Reiterated: Buy
Price Target: $12 → $12
Current: $0.133
Upside: n/a
Nov 10, 2016
Downgraded: Hold
Price Target: $2.3
Current: $7.20
Upside: n/a
Nov 11, 2015
Upgraded: Buy
Price Target: n/a
Current: $0.0012
Upside: n/a
May 9, 2013
Reiterated: Buy
Price Target: $16
Current: $2.10
Upside: n/a